Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
Clinical trial NCT06221813 · COMPLETED
Trial details
- NCT number
- NCT06221813
- Sponsor
- Public Health Vaccines LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2024-09-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.